These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36879304)

  • 21. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation of an open-access model for scaling up methadone maintenance treatment.
    Madden LM; Farnum SO; Eggert KF; Quanbeck AR; Freeman RM; Ball SA; Schottenfeld RS; Shi JM; Savage ME; Barry DT
    Addiction; 2018 Aug; 113(8):1450-1458. PubMed ID: 29453891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
    Bazazi AR; Wickersham JA; Wegman MP; Culbert GJ; Pillai V; Shrestha R; Al-Darraji H; Copenhaver MM; Kamarulzaman A; Altice FL
    Contemp Clin Trials; 2017 Aug; 59():1-12. PubMed ID: 28479216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
    Schiff DM; Nielsen TC; Hoeppner BB; Terplan M; Hadland SE; Bernson D; Greenfield SF; Bernstein J; Bharel M; Reddy J; Taveras EM; Kelly JF; Wilens TE
    Am J Obstet Gynecol; 2021 Oct; 225(4):424.e1-424.e12. PubMed ID: 33845029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.
    Cooperman NA; Lu SE; Richter KP; Bernstein SL; Williams JM
    Nicotine Tob Res; 2018 Aug; 20(9):1152-1156. PubMed ID: 29059389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
    Gauthier G; Eibl JK; Marsh DC
    Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.
    Shrestha R; Altice FL; Karki P; Copenhaver MM
    AIDS Behav; 2018 Aug; 22(8):2640-2649. PubMed ID: 29582199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [No Abstract]   [Full Text] [Related]  

  • 30. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
    J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.
    Snell-Rood C; Willging C; Showalter D; Peters H; Pollini RA
    Subst Abus; 2021; 42(4):716-725. PubMed ID: 33284083
    [No Abstract]   [Full Text] [Related]  

  • 32. Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders.
    Osilla KC; Dopp AR; Watkins KE; Ceballos V; Hurley B; Meredith LS; Leamon I; Jacobsohn V; Komaromy M
    Addict Sci Clin Pract; 2022 Apr; 17(1):25. PubMed ID: 35395811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
    Nunes EV; Levin FR; Reilly MP; El-Bassel N
    J Subst Abuse Treat; 2021 Mar; 122():108196. PubMed ID: 33221125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarifying the role of the mental health peer specialist in Massachusetts, USA: insights from peer specialists, supervisors and clients.
    Cabral L; Strother H; Muhr K; Sefton L; Savageau J
    Health Soc Care Community; 2014 Jan; 22(1):104-12. PubMed ID: 24313729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
    Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
    J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Care Physicians' Views about Prescribing Methadone to Treat Opioid Use Disorder.
    Livingston JD; Adams E; Jordan M; MacMillan Z; Hering R
    Subst Use Misuse; 2018 Jan; 53(2):344-353. PubMed ID: 28853970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming medication stigma in peer recovery: A new paradigm.
    Krawczyk N; Negron T; Nieto M; Agus D; Fingerhood MI
    Subst Abus; 2018; 39(4):404-409. PubMed ID: 29432086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care.
    Lister JJ; Lister HH
    Rural Remote Health; 2021 Nov; 21(4):6770. PubMed ID: 34757760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Field Test of a Dialectical Behavior Therapy Skills Training-Based Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment.
    Cooperman NA; Rizvi SL; Hughes CD; Williams JM
    J Dual Diagn; 2019; 15(1):67-73. PubMed ID: 30646819
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.